Table of Contents
Breast cancer is the most common type of cancer in women in the UK. Causes of breast cancer include: Certain genetic mutations (like BRCA1 and BRCA2), and ethnic background can increase risk. Higher levels of oestrogen, progesterone, or testosterone, or exposure to them through hormone replacement therapy or contraceptives, can increase risk. Obesity, alcohol consumption, lack of breastfeeding, and not being physically active can also increase risk. Previous radiation therapy to the chest can increase the risk of breast cancer later in life. In a quest to improve breast cancer therapies, researchers are exploring the potent potential of bee venom as an anticancer agent. The venom of western honeybee, Apis mellifera, contains a variety of peptides, including melittin and apamin a complex compound that aids in the treatment of a number of ailments, including pain, inflammation, and cancer.
Current laboratory studies on animals suggest that it suppresses tumour growth and could even minimize the side effects of standard cancer treatments. Bee venom’s most abundant peptide melittin, has shown impressive anti-tumour activity by disrupting cancer cell membranes and inhibiting proliferation. These cocktail of biologically active compounds like melittin, apamin, and adolapin, has demonstrated the ability prevent metastasis, to induce apoptosis, and enhance the effects of chemotherapy. Despite its promise, bee venom therapy is still in early experimental stages, with safety and dosage concerns still under investigation. As dosage must be determined with caution, keeping in mind the tolerance levels of the patient. Also, therapy might not be suitable for individuals with a known history of severe allergic reactions to bee stings, patients with an immunocompromised systems or certain underlying medical conditions. require further evaluation.
